View:
Download DOC
Download PDF
Download XLS
SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 		 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Murray Corlis D
(Last) (First) (Middle)
100 ABBOTT PARK ROAD
(Street)
ABBOTT PARK IL 60064-6092
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
02/01/2012 		3. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES [ ABT ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Senior Vice President
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common shares without par value 32,383 D
Common shares without par value 6,936 I Profit Sharing Trust(1)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Option (right to buy)(2) 02/15/2005 02/14/2012 Common shares 1,890 53.625 D
Option (right to buy)(2) 02/15/2005 02/14/2012 Common shares 481 53.625 D
Option (right to buy)(3) 02/16/2009 02/15/2017 Common shares 1,900 52.54 D
Option (right to buy)(3) 02/16/2010 02/15/2017 Common shares 1,900 52.54 D
Option (right to buy)(3) 02/15/2009 02/14/2018 Common shares 1,934 55.56 D
Option (right to buy)(3) 02/15/2010 02/14/2018 Common shares 1,933 55.56 D
Option (right to buy)(3) 02/15/2011 02/14/2018 Common shares 1,933 55.56 D
Option (right to buy)(3) 02/20/2010 02/19/2019 Common shares 4,267 54.14 D
Option (right to buy)(3) 02/20/2011 02/19/2019 Common shares 4,267 54.14 D
Option (right to buy)(3) 02/20/2012 02/19/2019 Common shares 4,266 54.14 D
Option (right to buy)(4) 02/19/2011 02/18/2020 Common shares 3,234 54.5 D
Option (right to buy)(4) 02/19/2012 02/18/2020 Common shares 3,233 54.5 D
Option (right to buy)(4) 02/19/2013 02/18/2020 Common shares 3,233 54.5 D
Option (right to buy)(4) 02/18/2012 02/17/2021 Common shares 3,534 46.6 D
Option (right to buy)(4) 02/18/2013 02/17/2021 Common shares 3,533 46.6 D
Option (right to buy)(4) 02/18/2014 02/17/2021 Common shares 3,533 46.6 D
Explanation of Responses:
1. Balance in the Abbott Laboratories Stock Retirement Trust as of February 1, 2012.
2. Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.
3. Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
4. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
John A. Berry, by Power of Attorney for Corlis D. Murray 02/08/2012
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
POWER OF ATTORNEY


The undersigned constitutes and appoints LAURA J. SCHUMACHER, JOHN A. BERRY,
and STEVEN L. SCROGHAM, and each of them individually, as the undersigned's
true and lawful attorney-in-fact and agent, with full power of substitution
and resubstitution, for the undersigned and in the undersigned's name, place
and stead, to prepare and sign any and all Securities and Exchange Commission
("SEC") Notices of Proposed Sales of Securities pursuant to Rule 144 under
the Securities Act of 1933 on Form 144, all SEC statements on Forms 3, 4 and
5 as required under Section 16(a) of the Securities Exchange Act of 1934, and
any amendments to such forms, and to file the same with all exhibits thereto,
and other documents in connection therewith, with the SEC, granting unto said
attorney-in-fact and agent full power and authority to do and perform each act
and thing requisite and necessary to be done under said Rule 144 and Section
16(a), as fully for all intents and purposes as the undersigned might or
could do in person, hereby ratifying and confirming all that said attorney-
in-fact and agent may lawfully do or cause to be done by virtue hereof.

A copy of this power of attorney shall be filed with the SEC.  The
authorization set forth above shall continue in full force and effect until
the undersigned is no longer required to file Forms 144, 3, 4, or 5 or
if earlier, until the undersigned revokes such authorization by written
instructions to the attorney-in-fact.



   Date:  February 1, 2012

   /s/ Corlis D. Murray
   Signature of Reporting Person
   Corlis D. Murray,
   Name

Abbott Laboratories
100 Abbott Park Road
Abbott Park, IL 60064-6400